Regeneron Pharmaceuticals, Inc.
METHOD OF TREATING OSTEOARTHRITIS WITH AN ANTIBODY TO NGF

Abstract:

Methods are disclosed for treating osteoarthritis in a human subject in need thereof, comprising administering to the subject a therapeutically effective amount of an anti-human NGF antibody, or antigen-binding fragment thereof, wherein at least one symptom associated with osteoarthritis is prevented, ameliorated or improved.